Used in biomedical research to quantify levels of peroxisome proliferator-activated receptor gamma (PPAR-γ) in human samples. Commonly applied in studies related to metabolic disorders such as type 2 diabetes, obesity, and insulin resistance, where PPAR-γ plays a key regulatory role. Enables researchers to assess the expression and activity of PPAR-γ in cell cultures, tissue extracts, and serum samples. Widely used in drug development to evaluate the effects of therapeutic compounds on PPAR-γ signaling pathways. Supports investigation into inflammatory diseases, atherosclerosis, and certain cancers due to the receptor's involvement in cell proliferation, differentiation, and inflammation. Provides a reliable, high-throughput method for measuring PPAR-γ in clinical and experimental settings.